Siponimod for secondary progressive MS: help us make the case to NICE
NICE is assessing siponimod for secondary progressive MS (SPMS) to decide whether it should be prescribed by the NHS in England and Wales. Scotland and Northern Ireland will carry out separate appraisals.
The MS Trust will be explaining to NICE why we think siponimod should be made available on the NHS. To help us make a strong case, we want to hear your experiences of living with SPMS, your views on current NHS care for SPMS and your thoughts on siponimod.
We’d like to hear from you if you live in the UK and
- you have secondary progressive MS
- you have a different type of MS, but would like to add your views
- you are a partner / friend / relative / carer of someone with SPMS
- you are a health professional providing care for people with SPMS
Tell us what you think by completing this short questionnaire by 17 September.
Find out more
- Siponimod survey - help us make a strong case
- Siponimod - information about siponimod
- NICE asessment of siponimod
"Starting a podcast in lockdown helped us take ownership of the situation"
23 Apr 2021 - 00:00
Comedian, Jeanette and Poet, Lytisha, talk about how creating their own podcast, about life with MS, led to lots of laughs, feelings of empowerment and a sense of community during lockdown.
Twelve year old Lacey hasn't been able to hug her dad for a year
23 Apr 2021 - 00:00
Before lockdown Lacey visited her dad every other weekend, but Covid restrictions have meant she’s not been able to visit her dad in his care home and give him a hug since March 2020.
'This is my normal now. I rather like it.' Living with PPMS in lockdown
23 Apr 2021 - 00:00
John Peters tells us how his working life changed during lockdown and how he’ll be quite happy not to go back to ‘normal’.
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
